Search Results for: Dreamed diabetes

FDA approves diabetes management system

I’ve reported previously (see here) on the diabetes monitors from Israel’s DreaMed. The US FDA has just given approval to DreaMed’s Advisor Pro, to add to its EU approval. The software tells Type 1 diabetics how much insulin to use, … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

AI system for diabetes treatment

I reported previously (see here) on Israel’s DreaMed Diabetes monitors. DreaMed has just partnered with French company BioCorp to create an Artificially Intelligent system that integrates BioCorp’s Mallya smart cap for pen injectors with DreaMed’s Advisor Pro insulin analysis system. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

US approval for diabetes monitor

I reported previously (10th Mar) that Israel’s DreaMed received European approval for its Advisor Pro diabetes monitor. Now the US FDA has given its approval. Advisor Pro provides insulin delivery recommendations by analyzing information from diabetes pumps and glucose monitoring. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Glucose analyzer gets Europe approval

I reported previously (twice) about Israel’s DreaMed Diabetes monitors for analyzing the data from Continuous Glucose Monitors (CGMs). DreaMed has just received the CE mark from the European Union for its Advisor Pro product. https://www.timesofisrael.com/israeli-smart-software-harnesses-flood-of-data-to-manage-diabetes-care/ https://www.youtube.com/embed/_eMkeq0lrFc?rel=0

Posted in Israel's Medical Achievements | Leave a comment

Monitoring insulin levels

Israel’s DreaMed Diabetes is developing a decision support technology platform called the Advisor to determine optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes.  DreaMed has just raised $3.3 million for development. http://www.prnewswire.com/news-releases/dreamed-diabetes-raises-33-million-from-norma-investments-and-a-strategic-investor-300303138.html

Posted in Israel's Medical Achievements | Leave a comment

Diabetic technology goes global

Israeli medical tech firm DreaMed Diabetes has struck a deal with Medtronic, the world’s biggest medical device company, to use its MD-Logic Artificial Pancreas algorithm in Medtronic’s insulin pumps. The algorithm regulates the insulin released to the diabetic individual. http://www.timesofisrael.com/diabetics-worldwide-to-benefit-from-artificial-pancreas/

Posted in Israel's Medical Achievements | Leave a comment